← All organizations

Kuros Biosurgery AG

For profitWebsite ↗

Also known as: Kuros BioSciences BV | Kuros Biosurgery | Kuros Biosurgery AG | Kuros Biosurgery AG, Technoparkstrasse 1, CH-8005 Zurich

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Mar 6, 2020

Timeline

2000s

Jun 1, 2000
Kuros Biosurgery AG— Founded

2010s

Jan 28, 2016
Cytos Biotechnology AG— Acquired

Drugs by trial phase (14 distinct, 22 trials)

Phase 2 (5 own, 8 via acquisition)

Phase 1 (0 own, 1 via acquisition)

cyt013-il1bqb

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Cytos Biotechnology AG

Recent trials (8)

NCT04294004Lead sponsorPhase 2Mar 6, 2020
NCT04294004CollaboratorPhase 2Mar 6, 2020
NCT00459641Study directorPhase 2Dec 1, 2012
NCT00459641Lead sponsorPhase 2Dec 1, 2012
NCT00915486Lead sponsorPhase 2May 1, 2009
NCT00915486Study directorPhase 2May 1, 2009
NCT00471939Lead sponsorPhase 2Apr 30, 2007
NCT00471939Sponsor investigatorPhase 2Apr 30, 2007

Details

Founded: Schlieren, CH Jun 1, 2000
Last known activity: Mar 6, 2020